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Peroxisomes play a catabolic role in the b-oxidation of
very-long-chain fatty acids1—3) and poly-unsaturated fatty
acids.4—6) These organella also have an anabolic role in the
biosynthesis of cholesterol,7—10) bile acids11—13) and plas-
malogen.14—16) We have reported that acetyl-CoA derived
from peroxisomal b-oxidation is utilized for anabolic metab-
olism.17—20) The activity of the peroxisomal b-oxidation sys-
tem of rats is greatly increased by treatment with clofibrate, a
peroxisome proliferator, while that of 3-hydroxy-3-methyl-
glutaryl-CoA (HMG-CoA) reductase, the rate-limiting en-
zyme of cholesterol biosynthesis, is significantly decreased.
Under these conditions, acetyl-CoA from peroxisomes is uti-
lized for the biosynthesis of plasmalogen.19,20) In other
words, acetyl-CoA from peroxisomal b-oxidation is incorpo-
rated into the 1-alkenyl group of ethanolamine plasmalo-
gen.20)
In plasmalogen biosynthesis, the first reaction is formation
of 1-acyl dihydroxyacetone-phosphate (DHAP) from acyl-
CoA and DHAP. The next step is replacement of the acyl
moiety with fatty alcohol, forming 1-alkyl DHAP, which is
then reduced to 1-alkyl glycerophosphate (GP). After a few
steps, 1-alkyl GP finally forms 1-alkenyl 2-acyl glycero-3-
phosphoethanolamine, i.e.: ethanolamine plasmalogen.
Biosynthesis up to 1-alkyl GP takes place exclusively in per-
oxisomes.14—16)
We reported that the fatty alcohol destined to form the 1-
alkenyl group of plasmalogen is not of extraperoxisomal ori-
gin, but is synthesized as nascent fatty alcohol within peroxi-
somes.21) Furthermore, acetyl-CoA utilized for the synthesis
of this nascent fatty alcohol is supplied by peroxisomal b-ox-
idation.20) Horie et al.22) reported that peroxisomal chain
elongation of acyl-CoA with octanoyl-CoA as the primer
forms dodecanoyl-CoA. Recently, we reported that peroxi-
somes can utilize dodecanoyl-CoA as a primer, and form
mainly hexadecanol, accompanied by chain elongation using
acetyl-CoA.23) Thus, we estimated that in plasmalogen
biosynthesis, peroxisomes degrade ordinary long chain fatty
acids to form octanoyl-CoA, and the resulting acetyl-CoA is
partly utilized for chain elongation of octanoyl-CoA, forming
dodecanoyl-CoA, and then partly utilized for biosynthesis of
fatty alcohol (hexadecanol) from this dodecanoyl-CoA.23)
Peroxisomes can oxidize long chain and very long chain
fatty acids. In this experiment, we studied what length of car-
bon-chain acyl-CoA(s), which can be utilized as a primer for
fatty alcohol synthesis, would be generated by peroxisomal
b-oxidation of long chain fatty acid. After palmitate and
stearate were incubated with peroxisomes, acyl-CoAs formed
by b-oxidation were analyzed.
MATERIALS AND METHODS
Materials [U-14C]Palmitate (3.7 MBq/mmol, 0.1 mCi/
mmol) and Aquazol 2 were purchased from New England
Nuclear (U.S.A.). [9,10-3H]Palmitate (3.7 MBq/mmol, 0.1
mCi/mmol) and [9,10-3H]stearate (3.7 MBq/mmol, 0.1 mCi/
mmol) were obtained from American Radiolabeled Chemi-
cals Inc. (U.S.A.). Various acyl-CoAs (C2 : 0, C4 : 0, C6 : 0, C8 : 0,
C10 : 0, C12 : 0, C14 : 0, and C16 : 0), Nycodenz, NAD
1, NADP1,
CoA, ATP, dithiothreitol and antimycin A were obtained
from Sigma (U.S.A.). Clofibrate, lactate dehydrogenase,
pyruvate and all other reagents were of analytical grade and
were purchased from Wako Pure Chemicals (Japan).
Animals Male Wistar rats weighing about 200 g were
maintained in a light- and temperature-controlled environ-
ment and fed Clea chow CE-2 (Nihon Clea Inc., Tokyo,
Japan) for at least 7 d prior to use. Then the rats were fed a
chow containing 0.25% clofibrate for 14 d. Clofibrate in-
creases peroxisome proliferation as well as fatty acyl-CoA b-
oxidation, but decreases HMG-CoA reductase. Augmentative
acetyl-CoAs from the increased peroxisomal b-oxidation
consequently flows mainly to the 1-alkenyl group of eth-
anolamine plasmalogens.
Preparation of Peroxisomes from Rat Liver The livers
were excised from the rats treated with clofibrate. A 10%
liver homogenate was prepared in 0.25 M sucrose containing
5 mM Hepes (pH 7.4), 1 mM EDTA and 1% ethanol (SVEH).
600 Biol. Pharm. Bull. 24(6) 600—606 (2001) Vol. 24, No. 6
* To whom correspondence should be addressed. e-mail: hhayashi@josai.ac.jp © 2001 Pharmaceutical Society of Japan
Accumulation of Medium Chain Acyl-CoAs during b-Oxidation of Long
Chain Fatty Acid by Isolated Peroxisomes from Rat Liver
Fumie HASHIMOTO, Yasuko FURUYA, and Hidenori HAYASHI*
Department of Pathological Biochemistry, Faculty of Pharmaceutical Sciences, Josai University, Keyakidai, Sakado,
Saitama 350–0295, Japan. Received December 5, 2000; accepted February 28, 2001
We have reported fatty alcohol synthesis accompanied by chain elongation in liver peroxisomes (Biochim.
Biophys. Acta, 1346, 38 (1997)). In the present experiment, we studied what kind of acyl-CoA(s) destined to be
utilized as primer for fatty alcohol synthesis accumulate(s) during peroxisomal b-oxidation. Peroxisomes were
prepared from rat liver treated with clofibrate, a peroxisome proliferator, and incubated with [U-14C]palmitate,
in order to investigate acyl-CoAs after b-oxidation. At 1 mM concentration, MgATP activated b-oxidation, but in-
hibited b-oxidation at concentrations higher than 1 mM. After incubation of peroxisomes with palmitate, various
acyl-CoAs were formed. Among medium-chain labelled acyl-CoAs, octanoyl-CoA was mainly detected. These re-
sults suggest that octanoyl-CoA accumulates during b-oxidation of palmitate. When peroxisomes were incubated
with [9,10-3H]palmitate and [9,10-3H]stearate, among medium-chain acyl-CoAs, octanoyl-CoA and decanoyl-
CoA were primarily detected, respectively, suggesting the occurrence of at least 4 cycles of b-oxidation of both
fatty acids by peroxisomes.
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The light mitochondrial fraction was prepared according to
the method of de Duve et al.24) with a slight modification.
The light mitochondrial fraction from 10 g of the liver was
suspended in SVEH, layered over 25 ml of 27.7% Nycodenz-
SVEH medium (d.51.175) in a 30-ml Hitachi centrifugation
tube and centrifuged at 630003g for 30 min at 4 °C in a Hi-
tachi P65-1021N ultracentrifuge using an angle rotor (Hi-
tachi RP50T).25) The precipitate fraction was suspended in
about 30 ml of SVEH and centrifuged at 200003g for
30 min for washing. The resulting pellet was suspended in an
appropriate amount of SVEH, and this was used as the per-
oxisomal preparation in the present experiment.
Peroxisomal Incubations and Assay of Peroxisomal b-
Oxidation Peroxisomal fractions were incubated using
nonsolubilizing (iso-osmotic) incubation conditions. Unless
otherwise stated, the incubations (1 ml) contained 130 mM-
KCl, 20 mM-Hepes, 0.1 mM-EGTA, 0.5 mM-NAD1, 0.1 mM-
NADP1, 0.4 mM-CoA, 1 mM-MgATP, 0.1 mM-dithiothreitol, 2
units of lactate dehydrogenase/ml, 20 mM-pyruvate, 10 mg of
antimycin A/ml and 2 mg of defatted BSA/ml, pH 7.2. The
substrate was always [U-14C]palmitate (200000 dpm), which
was added as a complex with BSA. The incubations usually
contained about 0.05 mg of peroxisomal protein/ml, and were
carried out at 37 °C in a shaking water bath.
Peroxisomal b-oxidation of [U-14C]palmitate was mea-
sured as acid-soluble radioactivity released after various peri-
ods of incubation. An aliquot (100 m l) of the incubation mix-
tures was usually withdrawn and added to an equivalent vol-
ume of ice-cold HClO4 (10% v/v). The radioactivity in the
supernatant was measured after a brief centrifugation to re-
move denatured proteins.26)
A minor mitochondrial contaminant is contained in the
peroxisomal fractions. However, when free palmitate is used
as a peroxisomal substrate, the resulting palmitoyl-CoA is es-
sentially unavailable for mitochondrial b-oxidation because
carnitine has not been added to the incubation mixture. It is
also well established that few, if any, intermediates accumu-
late during mitochondrial b-oxidation. It is therefore unlikely
that a significant portion of the intermediates observed was
due to contaminating mitochondrial activity.
Preparation of Fraction Containing Acyl-CoA Esters
After various periods of incubation, 900 m l of ice-cold glacial
acetic acid was added to the resulting sample, and heptade-
canoyl-CoA (40 nmol/ml) was added as an internal standard.
Also, 144 m l of saturated (NH4)2SO4 was added, and the tube
was placed in a boiling-water bath for 2 min, and then al-
lowed to cool to room temperature. Each sample was ex-
tracted with 18 ml of diethyl ether and again with 14 ml of di-
ethyl ether to remove free palmitate. An aqueous layer con-
taining acyl-CoAs was extracted for 1 h with 12 ml of
methanol/chloroform (2 : 1, v/v) with continuous shaking.
After centrifugation (400003gav·min), the supernatant was
retained. The pellet was resuspended in 4.5 ml of methanol/
chloroform (2 : 1, v/v) and re-centrifuged. The solvent was
reduced from the combined supernatants under N2 blowing at
60 °C until the volume was about 2 ml. The pH was adjusted
to 6—7 by adding 2.0 ml of 1 M-ammonium acetate, and the
sample was freeze-dried.
The residue was extracted with 2.4 ml of methanol and
centrifuged at 30003g for 30 min, and the supernatant was
retained. The pellet was resuspended in 0.8 ml of methanol
and re-centrifuged, and the solvent was removed from the
combined supernatants under N2 gas. The residue was dis-
solved in 5% acetonitrile in 50 mM-KH2PO4, pH 5.3 and ana-
lyzed by HPLC.26—28)
HPLC Analysis of Acyl-CoA Esters A Shimadzu Se-
ries LA-10 HPLC apparatus (Shimadzu, Japan) with a 5-mm
LiChrospher 100 RP-18 column (43250 mm) (Merck, Ger-
many) was used for HPLC. The column was maintained at
40 °C. All solvents were degassed with helium. The mobile
phase was the following gradient of acetonitrile in 50 mM-
KH2PO4, pH 5.3 : isocratic 5% (v/v), 5 min; isocratic 10%,
0.1 min; linear gradient 10—30%, 9.9 min; linear gradient
30—60%, 40 min; linear gradient 50—5%, 5 min. The mo-
bile phase was pumped at a constant rate of 1.5 ml/min. The
column was re-equilibrated for at least 20 min under the
starting conditions between analyses to maintain repro-
ducibility of retention times. The ultraviolet absorbance of
the column eluate was monitored with an SPD-10A Shima-
dzu UV spectrophotometric detector at 210 nm. Retention
times of acetyl-CoA, butyryl-CoA, hexanoyl-CoA, octanoyl-
CoA, decanoyl-CoA, dodecanoyl-CoA, tetradecanoyl-CoA,
palmitoyl-CoA, heptadecanoyl-CoA and stearoyl-CoA were
5.03, 10.81, 14.70, 18.76, 23.76, 31.97, 38.90, 44.48, 51.02
and 55.08 min, respectively. Peak fractions corresponding to
various acyl-CoAs were collected and concentrated. Ra-
dioactivity was measured using an Aloka-LSC 700 scintilla-
tion counter (Tokyo), with Aquazol 2 (New England Nuclear,
Boston, MA, U.S.A.) as a scintillator.27,28)
Enzyme and Protein Assays To estimate the purity of
the peroxisomal preparation, the activities of catalase, cy-
tochrome-c oxidase, esterase and acid phosphatase were de-
termined as markers of peroxisomes, mitochondria, micro-
somes and lysosomes, respectively. Catalase was estimated
by the method described in our previous report.29—31) Cy-
tochrome-c oxidase was determined by the method of Whar-
ton and Tzagoloff.31,32) Esterase was measured using o-nitro-
phenyl acetate as a substrate according to the method of Bea-
ufay et al.33) Acid phosphatase was determined by the
method in our previous report.30)
Protein was determined by the Lowry method34) using
bovine serum albumin as a standard. Since Nycodenz inter-
feres with the determination of protein, it was separated by
co-precipitation of the protein with deoxycholate and
trichloroacetic acid before determination.
RESULTS
Preparation of Peroxisomes Using Nycodenz Density
Centrifugation The liver was excised from a rat treated
with clofibrate. Peroxisomes were prepared from the light
mitochondrial fraction of liver homogenate by Nycodenz
density centrifugation. The result is shown in Table 1.
Peroxisomes were purified approximately 28-fold over
liver homogenate and were more than 94% pure, as calcu-
lated according to Leighton et al.29) This peroxisome prepa-
ration, which was contaminated with less than 4.8% of mi-
crosomes and less than 1.2% of mitochondria, was used in
the following experiment on fatty alcohol biosynthesis.
Effect of MgATP on Peroxisomal b-Oxidation When
peroxisomes were incubated with [U-14C]palmitate, the ef-
fects of MgATP on fatty acid b-oxidation were studied. Incu-
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bation was performed in the presence of 0.25 or 0.4 mM CoA.
The result is shown in Fig. 1.
The b-oxidation activity was increased by the addition of
MgATP, and was the highest at the MgATP concentration of
1 mM. The activity in the presence of 1 mM MgATP was 16.4
times greater than the control (absence of MgATP). At con-
centrations of MgATP higher than 1 mM, the activity was de-
creased, resulting in 27.5% and 7.3% of the highest activity
in the presence of 5 mM and 10 mM MgATP, respectively. Os-
mundsen and collaborators had performed the experiment at
5 and 10 mM MgATP,26,35) but our data indicated that the re-
action might be inhibited by MgATP at these concentrations.
Therefore, we performed the experiment using 1 mM MgATP.
Bartlett et al. used 0.2 mM CoA in the b-oxidation reac-
tion.26) When we compared the effect of 0.2 mM and 0.4 mM
CoA on b-oxidation activity, the activity at 0.4 mM was 2.23
times that at 0.2 mM (Fig. 1). Therefore, we used 0.4 mM
CoA.
Effects of Incubation Time on the b-Oxidation Activity
of [U-14C]Palmitate and on the Pattern of Acyl-CoA In-
termediates We studied the time course of the b-oxidation
activity of peroxisomes using [U-14C]palmitate as a substrate.
The reaction was performed in the presence or absence of
pyruvate and lactate dehydrogenase, which are regeneration
systems of NAD1. The result is shown in Fig. 2. b-Oxidation
activity was increased for at least 30 min.
The activity in the presence of pyruvate and lactate dehy-
drogenase was increased approximately 1.5 fold compared to
that in the absence of pyruvate and lactate dehydrogenase.
These results were consistent with those of Bartlett et al.26)
Namely, b-oxidation reaction might have been performed
smoothly, since NAD1 was regenerated from NADH, which
is a by-product of b-oxidation, by the lactate dehydrogenase
reaction.
Typical patterns of acyl-CoA esters synthesized from b-
oxidation of [U-14C]palmitate are shown in Fig. 3; acetyl-
CoA is not shown in the Figures. After incubation for 5 min,
the radioactivity of palmitoyl-CoA was low. Therefore, a
small amount of added palmitate seemed to have changed to
CoA ester. However, acyl-CoAs were detected, the chain
lengths of which are shorter than that of palmitoyl-CoA.
Thus, a small amount of palmitoyl-CoA seems to be synthe-
sized and further oxidized. After incubation for 10 min, the
amounts of palmitoyl-CoA and acetyl-CoA were each in-
creased about 5.7 times as compared with those after 5 min.
In other words, palmitate seems to be sufficiently changed to
CoA ester and oxidized, forming a great deal of acetyl-CoA.
After incubation for 30 min, palmitoyl-CoA was decreased
and acetyl-CoA was increased. This means that the reaction
was developing further with time. As shown in Fig. 3, acyl-
CoAs of various chain lengths were detected after b-oxida-
tion, but among medium-chain acyl-CoAs, mainly octanoyl-
CoA was synthesized after 20 min of the incubation. The re-
action did not stop at the chain length of octanoyl-CoA, and
acyl-CoAs of shorter chain length were also detected. How-
ever, the amount of octanoyl-CoA was increased with time.
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Table 1. Purification of Peroxisomes from Rat Liver
Protein (mg/g liver) Catalase Esterase Cyt. C oxidase Acid phosphatase
Homogenate 2666122 S.A. 68.3631.8 (1) 1.1160.38 (1) 6.0661.32 (1) 0.01960.001 (1)
kk100%ll T.A. 125306480 407619 1778617 7.3960.45
Purified 1.5460.36 S.A. 19406584 (28.4) 0.26160.009 (0.24) 0.37360.14 (0.06) 0.002560.001 (0.13)
peroxisomes kk0.58%ll T.A. 287161291 kk22.9ll 0.70960.121 kk0.17ll 0.51760.194 kk0.029ll 0.00360.001 kk0.041ll
Compartmentalization as peroxisomes: as microsomes: as mitochondria: as lysosomes:
(%) .93.7 ,4.80 ,1.23 ,0.26
S.A.: units/mg protein (purity over homogenate), T.A.: units/g liver (recovery from homogenate). Rats were fed a chow containing 0.25% clofibrate for 14 d. The light mito-
chondrial fraction was prepared in 0.25 M sucrose containing 5 mM HEPES, 1 mM EDTA and 0.1% ethanol, and centrifuged in 27.7% Nycodenz at 630003g for 30 min, as de-
scribed in the text. The precipitate was used as the peroxisomal preparation. S.A. and T.A. are specific activity and total activity, respectively.
Fig. 1. Effect of MgATP on Peroxisomal b-Oxidation Using [U-14C]-
Palmitate
Isolated peroxisomal fractions were incubated with 200 mM [U-14C]palmitate in the
presence of 0.2 mM (s) or 0.4 mM CoA (d). At 20 min, samples of the incubations
(100 m l) were removed for measurement of acid-soluble radioactivity as described in
the text. The incubations contained 0.05 mg of peroxisomal protein/ml. Typical data of
3 experiments are shown.
Fig. 2. Time Course of Peroxisomal b-Oxidation Using [U-14C]Palmitate
as a Substrate
Isolated peroxisomal fractions were incubated with 200 mM [U-14C]palmitate, in the
presence (d) or absence (s) of 20 mM-pyruvate plus 2 units of lactate dehydroge-
nase/ml. At the time points indicated, samples of the incubations (100 m l) were removed
for measurement of acid-soluble radioactivity. The incubation mixture contained
0.05 mg of peroxisomal protein/ml.
Effect of the Concentration of [U-14C]Palmitate on the
Pattern of Acyl-CoA Intermediates b-Oxidation activity
after incubation with various concentrations of [U-14C]palmi-
tate is shown in Fig. 4. The reaction was performed with 3
concentrations (0.025, 0.05, and 0.1 mg/ml) of peroxisomal
protein. With low concentrations of the protein (0.025 and
0.05 mg/ml), b-oxidation activity was increased in proportion
to the concentration of the substrate. The activity approxi-
mately plateaued at a substrate concentration of 200 mM and
above. However, with high concentrations of peroxisomal
protein (0.1 mg/ml), the activity was increased depending on
the substrate concentration up to at least 400 mM. This indi-
cates that with low concentrations of peroxisomal protein,
substrate concentrations of 200 mM and above are sufficient
for peroxisomal b-oxidation, but high concentrations of per-
oxisomes are not saturated by such substrate concentrations.
Patterns of acyl-CoAs synthesized with low concentrations
of the protein are shown in Fig. 5. Various acyl-CoAs were
synthesized. Among medium chain acyl-CoAs, octanoyl-
CoA was the main one detected at a substrate concentration
of 200 mM and above (Figs. 5a, b). Therefore, when [U-
14C]palmitate was used as a substrate, among medium-chain
acyl-CoAs, octanoyl-CoA is synthesized by peroxisomal b-
oxidation, in the presence of sufficient substrate.
Comparison of b-Oxidation Activity and the Pattern of
Acyl-CoA Intermediates between [9,10-3H]Palmitate and
[9,10-3H]Stearate In the body, stearate as well as palmitate
is present, and so we were interested in whether the b-oxida-
tion products of stearate differ from those of palmitate.
Time courses of peroxisomal b-oxidation of [9,10-
3H]palmitate and [9,10-3H]stearate are shown in Fig. 6. Very
little difference in b-oxidation was detected between palmi-
tate and stearate.
Patterns of acyl-CoAs intermediates are shown in Fig. 7.
In the case of palmitate, palmitoyl-CoA was already synthe-
sized after 10 min, and the reaction continued. The amount of
palmitoyl-CoA after 20 min of incubation was reduced by
half after 10 min, the resulting various acyl-CoAs were syn-
thesized, and among the medium chain acyl-CoAs, mainly
octanoyl-CoA was detected (Fig. 7a). Since only 9 and 10
carbon atoms sites were radiolabeled, radioactivity of bu-
tanoyl- and hexanoyl-CoA could not be detected. In the case
of stearate, on the other hand, one cycle of b-oxidation was
already performed after 10 min, so that the palmitoyl-CoA
content was greater than that of stearoyl-CoA. After 20 min,
the palmitoyl-CoA was further oxidized, and various acyl-
CoAs were synthesized. Decanoyl-CoA content was greaer
than that of dodecanoyl-CoA and tetradecanoyl-CoA (Fig.
7b). Since we used [9,10-3H]stearate, radioactivity of bu-
tyryl-, hexanoyl- and octanoyl-CoA could not be detected.
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Fig. 3. Formations of [U-14C]Acyl-CoA Esters after Incubation with Peroxisomes
Peroxisomal fractions were incubated with 200 mM [U-14C]palmitate, as described in the legend to Fig. 2. At the time points indicated, samples (900 m l) were mixed with 900 m l
of ice-cold glacial acetic acid. The acyl-CoA esters were subsequently extracted and chromatographed. The resulting data are presented as histograms, for incubations in the pres-
ence of 10 mM-pyruvate plus 2 units of lactate dehydrogenase/ml. The identities of the various peaks of radioactivity are indicated: C16, [
14C]palmitoyl-CoA; C14, [
14C]tetrade-
canoyl-CoA; C12, [
14C]dodecanoyl-CoA; C10, [
14C]decanoyl-CoA; C8, [
14C]octanoyl-CoA; C6, [
14C]hexanoyl-CoA; C4, [
14C]butyryl-CoA; C2, [
14C]acetyl-CoA. The numbers in
parentheses at the top of the column represent content of acyl-CoA products.
Fig. 4. Effects of Various Concentrations of [U-14C]Palmitate Used as a
Substrate for Peroxisomal b-Oxidation
Peroxisomal fractions were incubated with various concentrations of [U-14C]palmi-
tate. The incubations contained 0.025 mg (n), 0.05 mg (d) or 0.1 mg (s) of peroxiso-
mal protein/ml. After 20 min of incubation, the samples were quenched for measure-
ment of acid-soluble radioactivity.
Peroxisomal b-oxidation acitivity was studied using vari-
ous concentrations (200 and 300 mM) of [9,10-3H]palmitate
and [9,10-3H]stearate. Hardly any difference in b-oxidation
activity between palmitate and stearate was detected, even
though the concentrations of both substrates were changed
(data not shown).
Patterns of acyl-CoA intermediates show that a relatively
high number of octanoyl-CoAs were synthesized when per-
oxisomes were incubated with 300 mM palmitate (Fig. 8a). In
the case of stearate, various acyl-CoAs formed, and among
medium chain acyl-CoAs, decanoyl-CoA was the main one
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Fig. 5. Effects of Various Concentrations of [U-14C]Palmitate on Acyl-CoA Esters Generated after Incubation with Peroxisomes
Peroxisomes were incubated with various concentrations of [U-14C]palmitate, as described in the legend to Fig. 4. The incubations contained 0.025 mg (a) or 0.05 mg (b) of per-
oxisomal protein/ml. After 20 min of incubation, the samples were quenched for HPLC analysis of [14C]acyl-CoA esters. The resulting data are presented as histograms.
Fig. 6. Time Course of b-Oxidation Using [9,10-3H]Palmitate and [9,10-
3H]Stearate as Substrates
Isolated peroxisomal fractions were incubated with 200 mM [9,10-3H]palmitate (d)
or [9,10-3H]stearate (s). At the time points indicated, samples of the incubations
(100 m l) were removed for measurement of acid-soluble radioactivity. The incubations
contained 0.07 mg of peroxisomal protein/ml.
Fig. 7. Acyl-CoA Esters Produced Using [9,10-3H]Palmitate and [9,10-
3H]Stearate as Substrates
Peroxisomal fractions were incubated with 200 mM [9,10-3H]palmitate (a) or [9,10-
3H]stearate (b), as described in the legend to Fig. 6. After 10 and 20 min of incubation,
the samples were quenched for HPLC analysis of [9,10-3H]acyl-CoA esters. The result-
ing data are presented as histograms. The identities of the various peaks of radioactivity
are indicated: C18, [
3H]stearoyl-CoA; C16, [
3H]palmitoyl-CoA; C14, [
3H]tetradecanoyl-
CoA; C12, [
3H]dodecanoyl-CoA; C10, [
3H]decanoyl-CoA; C8, [
3H]octanoyl-CoA; C2,
[3H]acetyl-CoA.
synthesized (Fig. 8b). In other words, although various acyl-
CoAs formed depending on the concentration of the added
substrate, among medium chain acyl-CoAs, octanoyl-CoA
and decanoyl-CoA were mainly detected using palmitate and
stearate as substrates, respectively. We do not deny the possi-
bility that the reaction continues and shorter-chain acyl-
CoAs form. However, peroxisomes are reported to prefer
longer chain length fatty acid as a substrate, rather than 6
carbon atoms.35,36) Therefore, even if the reaction proceeds,
few acyl-CoAs with chains shorter than hexanoyl-CoA may
be detected.
DISCUSSION
We studied what kind of acyl-CoA(s) destined to be uti-
lized as a primer for fatty alcohol synthesis is synthesized by
peroxisomal b-oxidation of long-chain fatty acids.
Various acyl-CoAs were formed by peroxisomal b-oxida-
tion of palmitate. Among medium-chain fatty acids, oc-
tanoyl-CoA was abundantly formed in the presence of suffi-
cient substrate and after incubation of at least 20 min (Figs.
3, 5, 7, and 8). Bartlett et al.26) reported that dodecanoyl-CoA
and tereadecanoyl-CoA were the primary fatty acids formed
when peroxisomal b-oxidation was performed at high con-
centrations of palmitate, a long-chain fatty acid. Their results
are not necessarily comparable to ours. In their experiment, 2
cycles and 1 cycle of peroxisomal b-oxidation were per-
formed, so that dodecanoyl-CoA and tereadecanoyl-CoA
formed, respectively. They performed b-oxidation reaction in
the presence of 5 or 10 mM MgATP.26,37) In the first reaction
of fatty acid b-oxidation, acyl-CoA must be synthesized
from free fatty acid, requiring ATP, CoA and Mg21. However,
it is known that high concentrations of Mg21 inhibit thiolase
reaction in b-oxidation systems.1,38) In their data, 3-oxo de-
rivative, a substrate of the thiolase reaction, accumulated.
They stated that thiolase reaction was a rate-limiting step of
b-oxidation under their conditions. Taken together with the
present data, the results of Bartlett et al. indicate that high
concentrations of MgATP inhibit thiolase reaction, prevent-
ing the b-oxidation reaction from proceeding smoothly.
Therefore, they detected relatively more long-chain fatty
acids than we did in our data. Such obstruction can also 
be interpreted from the point of view of protein concentra-
tion. They used peroxisomal protein concentrations of 0.5
and 0.21 mg/ml. However, we used a concentration of
0.05 mg/ml, which was 1/10—1/4 of their concentrations. In
other words, because thiolase reaction was inhibited by a
high concentration of MgATP, they required a high concen-
tration of peroxisomal protein.
From the experiment investigating the difference in fatty
acid b-oxidation between [9,10-3H]palmitate and [9,10-
3H]stearate, it was recognized that at least 4 cycles of b-oxi-
dation from both fatty acids are performed (Figs. 7 and 8).
Since only 9 and 10 carbon atom sites were radiolabeled, ra-
dioactivity could not be detected, even though more than 4
cycles of b-oxidation had occurred. Therefore, we cannot
deny the possibility that the reaction continued to proceed.
However, patterns of acyl-CoAs derived from [9,10-
3H]palmitate were similar to those from [U-14C]palmitate
from the viewpoint of accumulation of octanoyl-CoA (Figs.
3, 5, 7, and 8). Thus, under the present conditions, even if
more than 4 cycles of b-oxidation are performed, a small
amount of acyl-CoA may form.
Since octanoyl-CoA was abundantly synthesized, 4 cycles
of b-oxidation of palmitate may occur. Lazarow1) reported
that when he and his colleagues used 0.034 mg/ml of peroxi-
somal protein and 10 mM of palmitoyl-CoA in the enzyme re-
action of b-oxidation, they calculated 5 cycles of b-oxidation
from the amount of formed NADH and acetyl-CoA. This in-
dicates that if there is insufficient substrate for peroxisomes,
5 cycles of the reaction may take place. Reports show that
peroxisomal b-oxidation is performed in from 3 to 7 cycles,
and cycle numbers change depending on the experimental
conditions.39—41)
Plasmalogen synthesis starts from DHAP, which is formed
in the Embden–Meyerhof pathway. Fatty acyl-CoA is reacted
with 1-OH group of DHAP, forming 1-acyl DHAP, and then
fatty alcohol is replaced by the acyl group. Hajra and col-
leagues42,43) reported that peroxisomes participate in a few
steps of this pathway. Horie et al.22) reported that the fatty-
acid chain elongation reaction in which acetyl-CoA is added
to octanoyl-CoA as a primer occurs in peroxisomes and the
main product is dodecanoyl-CoA. Also, the enzyme that re-
duces fatty acid to fatty alcohol has been reported, but this
reaction is reversible.44) In our previous papers, we reported
that acetyl-CoA derived from peroxisomal b-oxidation is uti-
lized for phospholipid synthesis, and especially incorporated
into the subclass of plasmalogen.19,20) Nascent fatty alcohol
synthesized within peroxisomes is reported to be preferen-
tially utilized for plasmalogen synthesis.21) Furthermore, we
reported that peroxisomes can utilize dodecanoyl-CoA as a
primer, and form primarily hexadecanol, accompanied by
chain elongation using acetyl-CoA. Since tetradecanoyl-CoA
functioned about half as effectively as dodecanoyl-CoA, the
possibility that longer-chain fatty acyl-CoAs are directly uti-
lized for fatty alcohol synthesis may be very small or negligi-
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Fig. 8. Influence of Concentrations of [9,10-3H]Palmitate and [9,10-3H]-
Stearate on Acyl-CoA Products
Isolated peroxisomal fractions were incubated with 200 mM and 300 mM of [9,10-
3H]palmitate (a) or [9,10-3H]stearate (b). The incubations contained 0.07 mg of peroxi-
somal protein/ml. After 20 min of incubation, the samples were quenched for HPLC
analysis on [9,10-3H]acyl-CoA esters.
ble.23)
Therefore, we estimated that in plasmalogen biosynthesis,
peroxisomes degrade ordinary long chain fatty acids to form
octanoyl-CoA, and the resulting acetyl-CoA is partly utilized
for chain elongation of octanoyl-CoA, forming dodecanoyl-
CoA, and then is partly utilized for biosynthesis of fatty alco-
hol from this dodecanoyl-CoA.23) Decanoyl-CoA was accu-
mulated after b-oxidation of stearate (Figs. 7 and 8). It is re-
ported that activity of decanoyl-CoA as a primer for fatty-
acid chain elongation reaction was approximately 73% of
that of octanoyl-CoA.22) Thus, decanoyl-CoA may also be
useful for chain elongation. The present study suggests that
octanoyl-CoA and decanoyl-CoA as primer for chain elonga-
tion can be supplied by peroxisomal b-oxidation.
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